NEU 5.50% $16.15 neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-22

  1. 118 Posts.
    lightbulb Created with Sketch. 17
    An amazing turning point! Thank you for wording it this way.

    I can see that there may be another period of consolidation and support until the next milestone / announcement, but today represents the start of recurring revenue and real value to those who have waited for years for this life changing treatment.

    More details coming surely, on the uptake amongst the rett population, and nz 2591 too.

    i dont see any reason to "dump" or sell. If anything, long term holders might choose to manage risk due to their (now) large NEU holdings, which they have every right to do and may even feel some hesitation in doing so...
    Last edited by ImpetuousLady: 18/04/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.15
Change
-0.940(5.50%)
Mkt cap ! $2.064B
Open High Low Value Volume
$15.04 $16.33 $14.65 $25.91M 1.638M

Buyers (Bids)

No. Vol. Price($)
1 125 $16.15
 

Sellers (Offers)

Price($) Vol. No.
$16.20 1500 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.